Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials

This publication has 35 references indexed in Scilit:

• Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
  The Lancet, 2012
• The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial
  The Lancet, 2012
• Intravenous heparin for the treatment of intraluminal thrombus in patients with acute ischemic stroke: a case series
  Journal of NeuroInterventional Surgery, 2012
• The International Stroke Trial database
  Trials, 2011
• Can clinical features distinguish between immobile patients with stroke at high and low risk of deep vein thrombosis? Statistical modelling based on the CLOTS trials cohorts
  Journal of Neurology, Neurosurgery & Psychiatry, 2011
• Prediction of Major Vascular Events in Patients With Transient Ischemic Attack or Ischemic Stroke
  Stroke, 2010
• NICE and venous thromboembolism
  The Journal of Bone and Joint Surgery. British volume, 2010
• Can We Improve the Statistical Analysis of Stroke Trials?
  Stroke, 2007
• Use of Intravenous Heparin by North American Neurologists
  Stroke, 2002
• Low-Molecular-Weight Heparins and Heparinoids in Acute Ischemic Stroke
  Stroke, 2000